Tech Company Financing Transactions
Nucleonics Funding Round
On 9/30/2008, Nucleonics landed $116 thousand in financing from Quaker Partners.
Transaction Overview
Company Name
Announced On
9/30/2008
Transaction Type
Venture Equity
Amount
$116,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
13 Summit Square Center 305
Langhorne, PA 19047
USA
Langhorne, PA 19047
USA
Phone
Website
Email Address
Overview
Nucleonics is an emerging biotechnology company focused on the development of novel RNA interference-based therapeutics for viral and other diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Towarnicki
Chief Financial Officer
Richard Fitzgerald
Chief Medical Officer
Michael Young
Vice President
Annette Richter
Browse more venture capital transactions:
Prev: 9/30/2008: PlayPhone venture capital transaction
Next: 9/30/2008: SANRAD venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs